CannAssist International Corporation CNSC Archives - Page 2 of 2

WednesdayJan 06, 2021 12:53 pm

CannAssist International Corp.’s (CNSC) Proprietary CiBiDinol Technology Promises to Outperform Conventional CBD Oil for Superior Pain-Relief

Market for CBD-based pain relief products is growing rapidly, projected to reach $20 billion by 2024 CNSC is a biotech company that produces fast-acting CBD products under the Xceptol brand Xceptol products are formulated with exclusive technology that increases absorbability, bioavailability, shelf life Third-party testing on Xceptol suggests 400% increase in skin penetration, 300% increase in gut absorption when compared to regular oil-based CBD CannAssist International (OTCQB: CNSC), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company marketing the Xceptol consumer brand - a line of cannabidiol (“CBD”) products that promises increased absorption, bioavailability and longer shelf life.…

MondayDec 21, 2020 1:15 pm

CannAssist International Corp. (CNSC) Engages Communications Industry Leader IBN to Share Story, Reach Millions

CNSC partners with InvestorBrandNetwork to maximize communication, refine messaging and outreach. CannAssist focused on marketing Xceptol consumer brand, which provides products featuring proprietary CiBiDinol technology. IBN brings 15-plus years of experience assisting more than 500 client partners improve communications within investment community. Recognizing the critical nature of communications to the success of a business, CannAssist International (OTCQB: CNSC) has selected to partner with InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities (https://ibn.fm/o1Oav). CannAssist, a biotechnological pharmaceutical and wellness company, owns Xceptor Labs, an R&D and raw material manufacturer, which also has its own product line. “We are pleased…

MondayDec 21, 2020 12:05 pm

QualityStocksNewsBreaks – CannAssist International Corporation’s (CNSC) Xceptol Brand Available via Innovative Distribution Portal – RangeMe

CannAssist (OTCQB: CNSC) today announced approval of its Xceptol brand on the distribution website RangeMe. According to the update, RangeMe added Xceptol drops and capsules to the Xceptol pain cream products already available, bringing the number of Xceptol SKUs on the platform to 10. Additional SKUs will be added in the first quarter of 2021. RangeMe's broad network creates a significant new revenue source for CannAssist International. "This is exciting news for us on many fronts; a process estimated to take weeks was accomplished in a few days – a testament, I feel, to the quality of the Xceptol brand,"…

WednesdayDec 16, 2020 2:29 pm

QualityStocksNewsBreaks – Why CannAssist International Corporation (CNSC) Is ‘One to Watch’

CannAssist (OTCQB: CNSC), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company. Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its consumer line of cannabidiol ("CBD") products under the Xceptol brand. A recent article discussing the company reads, “Xceptor Labs’ technology, CiBiDinol, is formulated using a proprietary process developed by CNSC founder Mark Palumbo. It is specifically designed to address many critical issues with oil-soluble CBD molecules, including delivery, bioavailability and short shelf-life. This technology provides the basis for Xceptor Labs and Xceptol consumer products.” To view the full article, visit https://ibn.fm/c2evM…

FridayDec 11, 2020 1:05 pm

CannAssist International (CNSC) Prepares to Take CBD Product Market by Storm

CannAssist International’s Xceptor Labs is active player within CBD-based product sector Global CBD product market is expected to rise in value from $4.6 billion in 2018 to over $23 billion by 2025 Xceptor Labs differentiating product range through use, development of proprietary CiBiDinol technology CiBiDinol technology covers the oil soluble CBD molecule with a water soluble carrier thereby increasing its bioavailability and enabling easier absorption of product Xceptor Labs has recently launched its Xceptol product line, comprised of topical pain creams, CBD-derived capsules, tinctures and pet drops CannAssist International (OTCQB: CNSC) is a biotechnological pharmaceutical and wellness company which has…

ThursdayDec 10, 2020 1:38 pm

QualityStocksNewsBreaks – CannAssist International Corporation (CNSC) Engages InvestorBrandNetwork for Corporate Communications Expertise

CannAssist (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company marketing the Xceptol consumer brand, today announced its selection of the corporate communications expertise of the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. CannAssist is the owner of Xceptor Labs, a research and development and raw material manufacturing outfit leveraging its proprietary CiBiDinol technology to create CBD products it believes have better absorption than currently marketed oil-based products. “The cannabidiol market has been on fire since the 2018 Farm Bill was signed into law. In 2018, the global CBD market was valued at $4.6…

FridayDec 04, 2020 11:54 am

QualityStocksNewsBreaks – CannAssist International Corporation’s (CNSC) Reg. A Offering Capital to Boost Continued Brand Expansion, Benchmarks

CannAssist (OTCQB: CNSC), a unique, enhanced cannabidiol (“CBD”) company, recently announced SEC approval of its Reg. A+ Tier 2 Filing as of Oct. 13, 2020, and an opportunity for investors to purchase shares at a set price stated in filing. “CannAssist International is building digital platforms, implementing a Brand PR and Sales/Marketing Campaign, expanding distribution, building inventory and enhancing the Xceptol brand,” said CannAssist’s CEO and Founder Mark Palumbo. “Gaining approval for the CNSC Reg A offering is an exciting milestone for us as it opens doors for new investors. The capital will help CannAssist’s continued expansion of the brand…

FridayDec 04, 2020 10:30 am

CannAssist International Corp. (CNSC) Is ‘One to Watch’

In July 2020, CannAssist International became among the first U.S.-based CBD companies to have its securities listed for trading onto a U.S. public capital market Xceptor Labs uses proprietary technology to create CBD products that it believes have better absorption than currently marketed oil-based products The company currently has five creams that utilize ingredients with National Drug Codes that are registered with the FDA The company’s Xceptol line of topical pain cream products, formulated using its proprietary CiBiDinol technology, was launched in September 2020. The company has since added capsules and, very soon, tinctures and pet drops The company’s marketing…

ThursdayDec 03, 2020 1:22 pm

QualityStocksNewsBreaks – CannAssist International Corporation (CNSC) Commences Trading on the OTCQB

CannAssist (OTCQB: CNSC), a unique, enhanced cannabidiol (“CBD”) company, recently commenced trading on the OTC Markets Platform - OTCQB Markets Tier. “Our Team has been working diligently for years to get to where we are now. Third party testing has revealed that our proprietary process used in our products can facilitate enhanced absorbency of CBD and aid in promoting connections with the endocannabinoid receptors that exist within all humans,” said CannAssist CEO and Founder Mark Palumbo. “We are very excited to get to launch our new enhanced CBD product, ‘Xceptol’ and assist as many as possible.” To view the full…

Site Search

Company Search

Tag: CannAssist International Corporation CNSC